Yuyu Pharma, Inc.

Research Yuyu Pharma, Inc. (000220.KS) on Bullrun: market cap KRW 59.13B, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 59.13B; dividend yield is 3.1%.

Peer valuation comparison

Latest dividend yield is 3.06% versus a Healthcare sector median of 2.4% (27.5% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 59.13Bn/a3.1%115

Dividend history

Latest trailing dividend snapshot: annual dividend/share 115 KRW, yield 3.1%.

About Yuyu Pharma, Inc.

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Yuyu Pharma, Inc.'s market cap?

Yuyu Pharma, Inc.'s market capitalization is KRW 59.13B.

Does Yuyu Pharma, Inc. pay a dividend?

Yuyu Pharma, Inc. has a dividend yield of 3.1%.

What does Yuyu Pharma, Inc. do?

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.